National Drug and Alcohol Research Centre, School of Public Health

Slides:



Advertisements
Similar presentations
Amanda Baxter Global Burden of Disease 2010 :
Advertisements

School of Public Health and Community Medicine HIV prevalence, incidence and mortality in prison: A global overview Professor Kate Dolan and Babak Moazen.
2007 National Drug Strategy Household Survey Results Australian Institute of Health and Welfare (AIHW) Graphs prepared by Paul Dillon Drug and Alcohol.
ARQ part II data management Training pack 4: Terminology.
The Effect of Opioid Agonist Maintenance Therapy on Healthcare Utilization and Engagement among HIV-infected People Who Inject Drugs in.
Louisa Degenhardt 1, Bradley Mathers 1, Peter Vickerman 2, Tim Rhodes 3, Carl Latkin 4 and Matt Hickman 5 1.National Drug and Alcohol Research Centre,
Annual report 2010: the state of the drugs problem in Europe.
Cost-effectiveness of harm reduction David P Wilson.
Return on investment: How do whole societies benefit from improved services and coverage for key populations? Bradley Mathers Kirby Institute UNSW Australia.
New Methamphetamine Epidemic in Thailand Apinun Aramrattana, MD, PhD Faculty of Medicine & Research Institute for Health Sciences, Chiang Mai University,
HIV/AIDS epidemics among men who have sex with men (MSM) in Africa, Asia, Latin America and the Caribbean, and the CIS Full Enjoyment of Human Rights by.
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
Substance Use among Older Adults (Age 50+): Current Prevalence and Future Expectations Presented by Joe Gfroerer U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES.
Prevention, Treatment and Care of Hepatitis C among People Who Inject Drugs Jason Grebely, PhD Senior Lecturer Viral Hepatitis Clinical Research Program.
00002-E-1 – 1 December 2001 Global summary of the HIV/AIDS epidemic, December 2001 Number of people living with HIV/AIDS Total40 million Adults37.2 million.
00002-E-1 – 1 December 2002 Global summary of the HIV/AIDS epidemic, December 2002 Number of people living with HIV/AIDS Total42 million Adults38.6 million.
60 Ferebee Enterprises International, LLC Global Female Empowerment o/ c
Health in Prisons Project Oslo, 24 November 2009 Lars Moller Regional Adviser a.i. World Health Organization Regional Office for Europe Health in Prisons.
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
 Reliant on robust monitoring systems  Emphasis changed over time  Limited by data collection systems available  Data collection adapts to allow wider.
Characterizing the HIV Epidemic in the Middle East The MENA HIV/AIDS Epidemiology and Response Synthesis Project is financed as a joint activity by the.
Research opportunities for PH training at LSHTM
Bloodborne viral and sexually transmissible infections in Aboriginal and Torres Strait Islander people: Annual Surveillance Report 2016.
Alcohol, Binge, and Blackouts
Incarceration and People Who Inject Drugs in Ukraine: Modelling its Role in HIV Transmission and the Impact of Introducing OST in Prisons Jack Stone, Ellen.
Epidemiology of Alcohol and Substance Misuse Among Migrants
India Maps Last updated: March 2016.
Needle and syringe exchange and working with injecting drug users
Harm reduction: decriminalising drug use in Asia
How does violence increase women’s vulnerability to HIV?
Global burden of HIV, viral hepatitis and TB in prisoners
Olga Varetska International HIV/AIDS Alliance in Ukraine
Global epidemiology of injecting drug use
Jack Stone, April Young, Jennifer R. Havens, Peter Vickerman
Recent incarceration and risk of hepatitis C and HIV transmission amongst people who inject drugs: A systematic review and meta-analysis Jack Stone, Hannah.
MODULE 2- EPIDEMIOLOGY OF DRUG USE IN THE AMERICAS
Hepatitis B and C management pathways in prison:
Bayesian ‘multi-parameter evidence synthesis’ in addictions research
Eighteen percent of adults in the United States have a mental, behavioral, or emotional disorder 12-month prevalence of any mental illness among adults.
SBIRT..What should I know?
Expanding the global profile of people who inject drugs: Summarising recent reviews Louisa Degenhardt.
2018 and Beyond: Outlook and Turning Points
Harm Reduction at the Crossroads Drugs, drug policy, harm reduction: A reality check International AIDS Conference July 25, 2018 Amsterdam Daniel.
DRUG USE WORLDWIDE AND HIV
Coverage of HIV and HCV prevention interventions for people who inject drugs Dr Sarah Larney, Senior Research Fellow.
Opioid overdose mortality trends in Australia
Mortality during Opioid Maintenance Treatment in Norway in the years 2014 and 2015 Anne Bech1, Thomas Clausen2, Helge Waal2,3, Ivar Skeie4,2 Norwegian.
22 November 2018 Factors predicting usage of low dead space syringes and association with Hepatitis C prevalence amongst people who inject drugs in the.
15% of Australians used an illicit drug (including using a pharmaceutical drug for non-medical purposes) in the previous 12 months.
Seek, test and treat continuum among a cohort of injecting drug users (IDUs) and their sexual partners in HIV prevention project in Kazakhstan Assel Terlikbayeva,
The Opioid Epidemic: Crisis in the Workplace
Royal Holloway, University of London
What about hepatitis and TB/MDR-TB: Why are we also failing PWID?
HIV, Anti-HCV And HBsAg in
Global Village Debate This house would ban information dissemination on safe injecting practices, and ban the provision of clean and sterile injecting.
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage.
Regular Cigarette Smoking Prevalence, Children:
Figure 2 Modelling the effect of HCV treatment on reinfection in people who inject drugs Figure 2 | Modelling the effect of HCV treatment on reinfection.
The cost-effectiveness of needle and syringe provision in preventing transmission of Hepatitis C Virus in people who inject drugs in the UK Zoë Ward1,
The HIV Epidemic among People who Inject Drugs
STIs among people who use drugs
The prevalence of non-fatal overdose among people who inject drugs
Tasmanian Drug Trends 2019: Methamphetamine use, markets and harms
2018 Postgraduate Research Symposium: Exploring opportunities
Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis 
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review 
Clinical Epidemiology and Global Health
Alcohol, Other Drugs, and Health: Current Evidence
No conflicts of interest
Teen vaping in Australia Does it increase smoking risk?
Presentation transcript:

National Drug and Alcohol Research Centre, School of Public Health The prevalence of non-fatal overdose among people who inject drugs: a multi-stage systematic review and meta-analysis Colledge, S.1, Peacock, A.1, Leung, J.1,2, Grebely, J.3, Hickman, M.4, Farrell, M.1, Larney, S.1, & Degenhardt, L.1 National Drug and Alcohol Research Centre, UNSW, Australia (2) School of Public Health, Faculty of Medicine, University of Queensland, Australia (3) Kirby Institute, UNSW, Australia (4) School of Social and Community Medicine, University of Bristol England

Countries with evidence of injecting drug use

Countries with an overdose estimate among people who inject drugs

Recent non-fatal overdose prevalence among people who inject drugs 1 in 5 PWID have recently overdosed ‘Recent’ def.: within the previous year North American estimates > global estimates Australasian estimates relatively small

Lifetime non-fatal overdose prevalence among people who inject drugs Nearly half of PWID have ever overdosed USA and Australia estimates > global estimate